Vor Biopharma (VOR) Revenue & Revenue Breakdown
Vor Biopharma Revenue Highlights
00
Vor Biopharma Revenue by Period
Vor Biopharma Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2018-12-31 | - | - |
Vor Biopharma Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | - | 100.00% |
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $12.23M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | - |
Vor Biopharma Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
KNSA | Kiniksa Pharmaceuticals | $270.26M | $112.21M |
ACLX | Arcellx | $110.32M | $26.03M |
KYMR | Kymera Therapeutics | $78.59M | $3.74M |
NRIX | Nurix Therapeutics | $76.99M | $12.59M |
FHTX | Foghorn Therapeutics | $34.16M | $7.81M |
BOLT | Bolt Biotherapeutics | $7.88M | $1.14M |
AUTL | Autolus Therapeutics | $1.70M | - |
STTK | Shattuck Labs | $1.66M | $1.61M |
LYRA | Lyra Therapeutics | $1.56M | $195.00K |
DSGN | Design Therapeutics | - | - |
CGEM | Cullinan Oncology | - | - |
GRCL | Gracell Bio | - | - |
NUVL | Nuvalent | - | - |
DAWN | Day One Biopharmaceuticals | - | $20.07M |
TALS | Tourmaline Bio | - | - |
ACET | Adicet Bio | - | - |
ERAS | Erasca | - | - |
VTYX | Ventyx Biosciences | - | - |
VOR | Vor Biopharma | - | - |
GLUE | Monte Rosa Therapeutics | - | $4.70M |
EWTX | Edgewise Therapeutics | - | - |